{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:08:58Z","timestamp":1792829338339,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.hfc.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T19:50:00Z","timestamp":1612554600000},"page":"207-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of Cardiac Magnetic Resonance Imaging in Heart Failure"],"prefix":"10.1016","volume":"17","author":[{"given":"Carla","family":"Contaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo","family":"Dellegrottaglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigida","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Rega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Scatteia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cittadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Cademartiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bossone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.hfc.2021.01.001_bib1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"14","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2021.01.001_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2021.01.001_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.hfc.2020.08.006","article-title":"Cardiovascular magnetic resonance in right heart and pulmonary circulation disorders","volume":"17","author":"Contaldi","year":"2021","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.hfc.2021.01.001_bib4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2009.04.094","article-title":"The role of cardiovascular magnetic resonance imaging in heart failure","volume":"54","author":"Karamitsos","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10741-017-9609-4","article-title":"Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!","volume":"22","author":"Aljizeeri","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hfc.2021.01.001_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2015.08.153","article-title":"Assessment of the relationships between left ventricular filling pressures and longitudinal dysfunction with myocardial fibrosis in uncomplicated hypertensive patients","volume":"202","author":"Contaldi","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2021.01.001_bib8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2019.06.030","article-title":"Myocardial tissue characterization and fibrosis by imaging","volume":"13","author":"Karamitsos","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib9","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/CIRCULATIONAHA.117.030693","article-title":"Cardiovascular magnetic resonance in acute ST-Segment-elevation myocardial infarction: recent advances, controversies, and future directions","volume":"137","author":"Bulluck","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.01.001_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2007.06.030","article-title":"Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis","volume":"50","author":"Nandalur","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcmg.2015.08.018","article-title":"Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal, myocardium without the need for gadolinium contrast agents","volume":"9","author":"Liu","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2021.01.001_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2459\/JCM.0b013e328362765e","article-title":"Cardiac magnetic resonance for the assessment of myocardial viability: from pathophysiology to clinical practice","volume":"14","author":"Dellegrottaglie","year":"2013","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.hfc.2021.01.001_bib14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ehjci\/jeu183","article-title":"T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy","volume":"16","author":"aus dem Siepen","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib16","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2021.01.001_bib17","doi-asserted-by":"crossref","first-page":"e003073","DOI":"10.1161\/CIRCIMAGING.114.003073","article-title":"Performance of T1 and T2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure","volume":"8","author":"Bohnen","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/ehjci\/jeaa149","article-title":"EACVI scientific documents committee. Multimodality imaging in takotsubo syndrome: a joint consensus document of the European association of cardiovascular imaging (EACVI) and the Japanese society of echocardiography (JSE)","volume":"21","author":"Citro","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib19","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.106.652016","article-title":"Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging","volume":"115","author":"Jahnke","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.01.001_bib20","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.jacc.2009.07.027","article-title":"Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging","volume":"54","author":"Kelle","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib21","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.106.653568","article-title":"Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction","volume":"115","author":"Schmidt","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.01.001_bib22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.113.002518","article-title":"The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy","volume":"128","author":"Gulati","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.01.001_bib23","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jcmg.2018.08.021","article-title":"Comparing CMR mapping methods and myocardial patterns toward heart failure outcomes in nonischemic dilated cardiomyopathy","volume":"12","author":"Vita","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib24","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2017.08.044","article-title":"Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY Study","volume":"70","author":"Aquaro","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib25","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischaemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2021.01.001_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/HCO.0b013e32830b3865","article-title":"Cardiac magnetic resonance assessment of mechanical dyssynchrony","volume":"23","author":"Helm","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib27","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2014.02.533","article-title":"Impact of mechanical activation, scar, and electrical timing on cardiac resynchronization therapy response and clinical outcomes","volume":"63","author":"Bilchick","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the heart failure association of the European society of cardiology","volume":"21","author":"Seferovi\u0107","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2021.01.001_bib29","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2021.01.001_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1532-429X-14-13","article-title":"Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"14","author":"Maron","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2021.01.001_bib31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.echo.2007.03.023","article-title":"Myocardial texture in hypertrophic cardiomyopathy","volume":"20","author":"Losi","year":"2007","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2021.01.001_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10554-020-01808-6","article-title":"Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy","volume":"36","author":"Raiker","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","article-title":"Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans","volume":"122","author":"Flett","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.01.001_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jmri.24962","article-title":"4D flow MRI and T1-mapping: assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy","volume":"43","author":"van Ooij","year":"2016","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","article-title":"T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib36","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","article-title":"Spectrum of restrictive and infiltrative cardiomyopathies: Part 1 of a 2-Part series","volume":"71","author":"Pereira","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib37","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","article-title":"The role of cardiac imaging in the diagnosis and management of anderson-fabry disease","volume":"12","author":"Perry","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12968-014-0099-4","article-title":"Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance","volume":"16","author":"Pica","year":"2014","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2021.01.001_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jcmg.2019.04.011","article-title":"Cardiac magnetic resonance T1 mapping for cardiac amyloidosis: the best way forward","volume":"13","author":"Karamitsos","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2005.03.045","article-title":"Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging","volume":"46","author":"Petersen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib41","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehp595","article-title":"Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction","volume":"31","author":"Jacquier","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2021.01.001_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1532-429X-15-36","article-title":"Quantification of left ventricular trabeculae using fractal analysis","volume":"15","author":"Captur","year":"2013","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2021.01.001_bib43","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2\u2217) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2021.01.001_bib44","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/jmri.24727","article-title":"Noncontrast myocardial T1 mapping using cardiovascular magneticresonance for iron overload","volume":"41","author":"Sado","year":"2015","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ehjci\/jew229","article-title":"Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European association of cardiovascular imaging","volume":"18","author":"Haugaa","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib46","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2021.01.001_bib47","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1532-429X-11-14","article-title":"Cardiovascular magnetic resonance in pericardial diseases","volume":"11","author":"Bogaert","year":"2009","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2021.01.001_bib49","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.01.001_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2021.01.001_bib51","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2\u2217 magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.01.001_bib52","doi-asserted-by":"crossref","first-page":"e003738","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2021.01.001_bib54","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","article-title":"Therapeutic clearance of amyloid by antibodies to serum amyloid P component","volume":"373","author":"Richards","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2021.01.001_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the American Heart Association","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.01.001_bib56","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/1440-1681.12916","article-title":"Novel cardiovascular magnetic resonance oxygenation approaches in understanding pathophysiology of cardiac diseases","volume":"45","author":"Sree Raman","year":"2018","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.hfc.2021.01.001_bib57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mri.2017.02.005","article-title":"Quantification of myocardial oxygenation in heart failure using blood-oxygen-level-dependent T2\u2217 magnetic resonance imaging: Comparison with cardiopulmonary exercise test","volume":"39","author":"Nagao","year":"2017","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.hfc.2019.02.010","article-title":"Evaluation of cardiac metabolism by magnetic resonance spectroscopy in heart failure","volume":"15","author":"Dellegrottaglie","year":"2019","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.hfc.2021.01.001_bib59","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jcmg.2019.07.016","article-title":"Diffusion tensor cardiovascular magnetic resonance imaging: a clinical perspective","volume":"13","author":"Khalique","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.01.001_bib60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12968-015-0174-5","article-title":"4D flow cardiovascular magnetic resonance consensus statement","volume":"17","author":"Dyverfeldt","year":"2015","journal-title":"J\u00a0Cardiovasc Magn Reson"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713621000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713621000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:42:23Z","timestamp":1761554543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713621000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1551713621000015"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2021.01.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Cardiac Magnetic Resonance Imaging in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}